Literature DB >> 1805712

[Synthesis and anticonvulsant activity of 3-carbamoyl-4-aryl-isoquinolin-1(2H)-ones].

K Unverferth1, R Dörre, B Körner, H Scheibe, E Morgenstern.   

Abstract

The syntheses of nineteen 3-carbamoyl-4-aryl-isoquinoline-1(2H)-ones are described. The compounds show anticonvulsant activity in maximal electroshock test (i.p. administration). A representative substance is 3-carbamoyl-2-isopropyl-4-(4-chlorophenyl)-isoquinoline-1(2H)-one, ED50 = 2.1 x 10(-4) mol/kg. This agent shows 20% of the activity of phenytoin (ED50 = 0.44 x 10(-4) mol/kg).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805712

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  2 in total

Review 1.  The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy.

Authors:  Chris Rundfeldt; Wolfgang Löscher
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

2.  Tertiary amine-directed and involved carbonylative cyclizations through Pd/Cu-cocatalyzed multiple C-X (X = H or N) bond cleavage.

Authors:  Qiu-Chao Mu; Yi-Xue Nie; Xing-Feng Bai; Jing Chen; Lei Yang; Zheng Xu; Li Li; Chun-Gu Xia; Li-Wen Xu
Journal:  Chem Sci       Date:  2019-08-19       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.